intermittent fasting with glp 1 and GLP-1 Added Value to GLP-1 Receptor

Skeletal muscle hypertrophy and atrophy signaling pathways

Neuroinflammation and energy metabolism: A dual perspective on ischemic stroke

If you experience any strange side effects after the therapy, make sure you immediately contact your healthcare professional

Additionally, it prevents platelet activation and thereby clot formation

Physiol Res (1991) 40(1):95102

In our systematic review and meta-analysis evaluating the clinical efficacy and safety of combinations of DPP-4 inhibitors and SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes, the combination of an SGLT2 inhibitor and a DPP-4 inhibitor showed a greater reduction in HbA1c (weighted mean difference, 0.6%), fasting plasma glucose, and 2-hour postprandial plasma glucose levels than the combination of a placebo with a DPP-4 inhibitor [47]